{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:49:18Z","timestamp":1790714958716,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To compare the diagnostic value of the SARC-F, MRSA-7 and MRSA-5 questionnaires in screening for sarcopenia in inpatients with chronic heart failure (CHF).<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p>A total of 355 CHF patients hospitalized from January 2019 to August 2019 who met the study\u2019s selection criteria were included in the analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements<\/jats:title><jats:p>Handgrip strength and gait speed were measured, and bioelectrical impedance analysis (BIA) was used to estimate appendicular skeletal muscle mass. The sensitivity\/specificity of the SARC-F, MRSA-7 and MRSA-5 questionnaires was evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The diagnostic criteria of the Asia Working Group for Sarcopenia (AWGS) were used as the gold standard for diagnosing sarcopenia. The prevalence of sarcopenia was 55.8% according to the AWGS diagnostic criteria, 31.0% according to the SARC-F, 73.0% according to the MRSA-7, and 71.3% according to the MRSA-5. Using the AWGS criteria as the gold standard, the SARC-F had a sensitivity of 52.5% and a specificity of 96.2% in the whole study population, the MRSA-7 had a sensitivity of 92.4% and a specificity of 51.6%, and the MRSA-5 had a sensitivity of 93.9% and a specificity of 57.3%. The areas under the ROC curves for the SARC-F, MRSA-7 and MRSA-5 were 0.78, 0.74 and 0.77, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The MSRA-7 and MSRA-5 may serve as novel screening tools for sarcopenia in hospitalized patients with CHF. The SARC-F, a classic screening tool, is also suitable for this population. The MSRA-7 and MSRA-5 have better sensitivity, whereas the SARC-F has better specificity.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s40520-020-01561-9","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T14:02:43Z","timestamp":1588082563000},"page":"339-344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The role of sarcopenia questionnaires in hospitalized patients with chronic heart failure"],"prefix":"10.1007","volume":"33","author":[{"given":"Wenxue","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"1561_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijcard.2010.10.028","volume":"156","author":"R Herrmann","year":"2012","unstructured":"Herrmann R, Sandek A, von Haehling S et al (2012) Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parameters. Int J Cardiol 156:62\u201368","journal-title":"Int J Cardiol"},{"key":"1561_CR2","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Hcart Fail 18:891\u2013975","journal-title":"Eur J Hcart Fail"},{"key":"1561_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jcsm.12118","volume":"7","author":"G Loncar","year":"2016","unstructured":"Loncar G, Springer J, Anker M et al (2016) Cardiac cachexia: hic et nune. J Cachexia Sarcopenia Muscle 7:246\u2013260","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1561_CR4","first-page":"760","volume":"46","author":"Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association, Chinese Heart Failure Association of Chinese Medical Doctor Association, Editorial Board of Chinese Journal of Cardiology","year":"2018","unstructured":"Heart Failure Group of Chinese Society of Cardiology of Chinese Medical Association, Chinese Heart Failure Association of Chinese Medical Doctor Association, Editorial Board of Chinese Journal of Cardiology (2018) Chinese guidelines for the diagnosis and treatment of heart failure 2018. Zhonghua Xin Xue Guan Bing Za Zhi 46:760\u2013789","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"1561_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jamda.2013.05.018","volume":"14","author":"TK Malmstrom","year":"2013","unstructured":"Malmstrom TK, Morley JE (2013) SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14:531\u2013532","journal-title":"J Am Med Dir Assoc"},{"key":"1561_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s12603-017-0921-4","volume":"21","author":"AP Rossi","year":"2017","unstructured":"Rossi AP, Micciolo R, Rule S et al (2017) Assessing the risk of sarcopenia in the elderly: The Mini Sarcopenia Risk Assessment (MRSA) Questionnaire. J Nutr Health Aging 21:743\u2013749","journal-title":"J Nutr Health Aging"},{"key":"1561_CR7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1177\/2047487319827460","volume":"26","author":"G Testa","year":"2019","unstructured":"Testa G, Liguori I, Curcio F et al (2019) Multidimensional frailty evaluation in elderly outpatients with chronic heart failure: a prospective study. Eur J Prev Cardiol 26:1115\u20131117","journal-title":"Eur J Prev Cardiol"},{"key":"1561_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2147\/CIA.S149232","volume":"13","author":"I Liguori","year":"2018","unstructured":"Liguori I, Russo G, Ara L et al (2018) Sarcopenia: assessment of disease burden and strategies to improve outcomes. Clin Interv Aging 13:913\u2013927","journal-title":"Clin Interv Aging"},{"key":"1561_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijcard.2017.03.155","volume":"238","author":"M Saitoh","year":"2017","unstructured":"Saitoh M, Ishida J, Doehner W et al (2017) Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016. Int J Cardiol 238:5\u201311","journal-title":"Int J Cardiol"},{"key":"1561_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jamda.2017.07.006","volume":"19","author":"S Kim","year":"2018","unstructured":"Kim S, Kim M, Won CW (2018) Validation of the Korean Version of the SARC-F questionnaire to assess sarcopenia: Korean Frailty and Aging Cohort Study. J Am Med Dir Assoc 19:40\u201345","journal-title":"J Am Med Dir Assoc"},{"key":"1561_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jamda.2014.04.021","volume":"15","author":"J Woo","year":"2014","unstructured":"Woo J, Leung J, Morley JE (2014) Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 15:630\u2013634","journal-title":"J Am Med Dir Assoc"},{"key":"1561_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s40520-016-0668-5","volume":"29","author":"S Ida","year":"2017","unstructured":"Ida S, Murata K, Nakadachi D et al (2017) Development of a Japanese version of the SARC-F for diabetic patients: an examination of reliability and validity. Aging Clin Exp Res 29:935\u2013942","journal-title":"Aging Clin Exp Res"},{"key":"1561_CR13","doi-asserted-by":"publisher","first-page":"809.e9","DOI":"10.1016\/j.jamda.2017.06.012","volume":"18","author":"S Ida","year":"2017","unstructured":"Ida S, Nakai M, Ito S et al (2017) Association between sarcopenia and mild cognitive impairment using the Japanese version of the SARC-F in elderly patients with diabetes. J Am Med Dir Assoc 18:809.e9\u2013809.e13","journal-title":"J Am Med Dir Assoc"},{"key":"1561_CR14","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.jamda.2016.09.008","volume":"17","author":"L Parra-Rodriguez","year":"2016","unstructured":"Parra-Rodriguez L, Szlejf C, Garcia-Gonzalez AI et al (2016) Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican community-dwelling older adults. J Am Med Dir Assoc 17:1142\u20131146","journal-title":"J Am Med Dir Assoc"},{"key":"1561_CR15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jamda.2016.07.029","volume":"17","author":"TY Wu","year":"2016","unstructured":"Wu TY, Liaw CK, Chen FC et al (2016) Sarcopenia screened with SARC-F questionnaire is associated with quality of life and 4-year mortality. J Am Med Dir Assoc 17:1129\u20131135","journal-title":"J Am Med Dir Assoc"},{"key":"1561_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jcsm.12048","volume":"7","author":"TK Malmstrom","year":"2016","unstructured":"Malmstrom TK, Miller DK, Simonsick EM et al (2016) SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7:28\u201336","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1561_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jamda.2018.11.020","volume":"20","author":"MD Ming Yang","year":"2019","unstructured":"Ming Yang MD, Xiaoyi Hu MSN, Lingling Xie MSN (2019) Comparing mini sarcopenia risk assessment with SARC-F for Screening sarcopenia in community-dwelling older adults. J Am Med Dir Assoc 20:1\u20135","journal-title":"J Am Med Dir Assoc"},{"key":"1561_CR18","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412\u2013423","journal-title":"Age Ageing"},{"key":"1561_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","volume":"15","author":"LK Chen","year":"2014","unstructured":"Chen LK, Liu LK, Woo J et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15:95\u2013101","journal-title":"J Am Med Dir Assoc"},{"key":"1561_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","volume":"12","author":"RA Fielding","year":"2011","unstructured":"Fielding RA, Vellas B, Evans WJ et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. international working group on sarcopenia. J Am Med Dir Assoc 12:249\u2013256","journal-title":"J Am Med Dir Assoc"},{"key":"1561_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/gerona\/glu010","volume":"69","author":"SA Studenski","year":"2014","unstructured":"Studenski SA, Peters KW, Alley DE et al (2014) The FNIH sarcopenia project:rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69:547\u2013558","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1561_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","volume":"34","author":"S Fulster","year":"2013","unstructured":"Fulster S, Taeke M, Sandek A et al (2013) Muscle wasting in patients with chronic heart failure: from the studies investigating co-morbidities Aggravating heart failure (SICA HF). Eur Heart J 34:512\u2013519","journal-title":"Eur Heart J"},{"key":"1561_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijcard.2016.07.135","volume":"222","author":"T Bekfani","year":"2016","unstructured":"Bekfani T, Pellicori P, Morris DA et al (2016) Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle Strength, Exercise capacity and quality of life. Int J Cardiol 222:41\u201346","journal-title":"Int J Cardiol"},{"key":"1561_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17987\/jcsm-cr.v2i2.41","volume":"2","author":"K Kamiya","year":"2017","unstructured":"Kamiya K, Hamazaki N, Matsuzawa R et al (2017) Sarcopenia: prevalence and prognostic implications in elderly patients with cardiovascular disease. JCSM Clin Rep 2:1\u201313","journal-title":"JCSM Clin Rep"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-020-01561-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-020-01561-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-020-01561-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T13:24:18Z","timestamp":1666445058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-020-01561-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1561"],"URL":"https:\/\/doi.org\/10.1007\/s40520-020-01561-9","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"10 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The research was approved by the medical ethics committee of the Second Affiliated Hospital of Nanjing Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The ethical committee approved the protocol.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement human right"}},{"value":"All participants were due informed and they provided consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}